Studies of Thorium X Applied to Human Skin III. the Relative Effects of Alpha and Beta-Gamma Irradiation in the Production of Erythema* by Witten, Victor H. et al.
STUDIES OF THORIUM X APPLIED TO HUMAN SKIN
III. THE RELATIVE EFFECTS OF ALPHA AND BETA-GAMMA IRRADIATIoN IN THE
PRODUCTION OF ERYTHEMA*
ViCTOR H. WITTEN, M.D., EARLE W. BEATER, M.D., VERA HOLMSTROM, B.A.
AND ROBERT LOEVINGER, PH.D.**
Many opinions have been voiced regarding the biologically effective radiation
emanating from thorium X; and various theories have been postulated to account
for the well-known erythema and pigmentation which follow the topical applica-
tion of this radioactive material to the skin of man.
It has been long established that as thorium X disintegrates to reach thorium
D (its stable form), it gives off alpha, beta and gamma radiation (Table I). Unlike
radium, from which the alpha rays are filtered, all three types of radiation are
present when thorium X is applied to human skin.
It has often been said that since alpha particles cannot pass through a thin
piece of paper, they cannot penetrate the epidermis and therefore cannot be ex-
pected to be biologically effective. This leads to the conclusion that if any biologic
effect is produced by thorium X, it must necessarily be due to the beta and/or
gamma radiation. In contrast, it has been said that the amount of beta and
gamma radiation given off by thorium X is insufficient to produce biologic effects,
and therefore it must be the alpha emanations which are responsible for the gross
and microscopic changes.
Lomholt (1) suggested that the histopathologic changes which he demonstrated
500 to 600 microns below the surface of human skin were due to thoron, the
gaseous emanation from thorium X, diffusing through the tissue following topical
application. Sulzberger (2) independently suggested that the vehicle carrying the
thorium X might penetrate certain of the epidermal structures and thus deposit
this radioactive material at various points below the surface. Our own investiga-
tions (3) (4) clearly demonstrated by the autoradiographic technic that thorium
X in selected vehicles penetrates the human epidermis and its appendages when
applied topically in vivo. In a recent article, Witten and Sulzberger (5) speculated
on the mode of action of thorium X applied to human skin and suggested other
mechanisms by which this radioactive material might produce biologic effects
when applied to the skin surface in various vehicles.
None of these observations or speculations, however, provide any information
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concerning the relative biologic effects of the alpha radiation as contrasted with
the beta-gamma radiation given off by thorium X. As early as 1923, Lomholt con-
cluded by simple experimentation that if the alpha rays from thorium X were
kept from the skin there was no gross evidence of biologic effect. This he accom-
plished by painting thorium X on the upper surface of a thin piece of gutta percha
which was then applied to the skin and permitted to remain in place for several
days. When the gutta percha was removed, no erythema was noted. Knowing
that the alpha rays from the thorium X could not penetrate the gutta percha he
concluded that the beta and gamma rays which did penetrate were insufficient
to produce erythema. He was of the opinion, therefore, that the alpha particles
were responsible for the biologic effects since an equal amount of thorium X in
alcoholic solution applied directly to the skin's surface would produce a clinically-
visible erythema.
In an attempt to shed more light on this controversial problem, we planned a
series of experiments which we hoped would explain whether it was the alpha or
beta-gamma rays (or a combination of these) emanating from thorium X which
were responsible for the erythema. For this purpose special thin-window plaques
were constructed into which thorium X solution could be pipetted (see Proce-
dure). The plaques were constructed to seal in the thorium X and thus prevent
the vehicle and the thorium X atoms from penetrating into the epidermis and its
appendages.
Two forms of these thin-window plaques were made:
1) A thorium X "alpha" plaque*: with a window material thin enough to trans-
mit essentially all of the alpha radiation (and, of course, the beta and gamma
radiation).
2) A thorium X "beta-gamma" plaque*: with a window material of sufficient
thickness to absorb the alpha particles but thin enough to transmit the beta and
gamma radiation.
In each instance the plaques were loaded with a quantity of thorium X which
if applied directly to the surface of the skin would regularly produce a distinct
erythematous response.
PROCEDURE
Principles Involved in Design of Plagues
Thorium X decays through a series of radioactive daughter products to an isotope of
stable lead. As it undergoes this decay, alpha, beta and gamma radiation is given off (Table
I). As the alpha particles travel away from their parent atom they lose energy very rapidly,
having a maximum range of about 10 mg/cm2.** The beta particles lose their energy less
rapidly than the alpha particles, with maximum ranges of about 1000 mg/cm2. Thus when
a plaque is covered with a material having a thickness of 10 mg/cm2 all of the alpha par-
ticles are absorbed and none can reach the skin; it is then solely a "beta-gamma" plaque.
* These names were given the two types of plaques solely for the purpose of this paper.
** Mg/cm2 is used to express absorber thickness in mass per unit area. This permits for
greater accuracy and eliminates the factor of density of the particular material used;
e.g. 1 mm. water = 100mg/cm2, and 1 mg/cm2 = 1O.
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Construction of Plaques
The first problem in the construction of suitable plaques was to find a window material
thin enough to permit the desired radioactive particles to pass through, without allowing
leakage of the thorium X. Polystyrene 10 mg/cm2 thick proved to be a satisfactory window
material for the "beta-gamma" plaques. However, for the "alpha" plaques it was neces-
sary to have an even thinner film—approximately 1 to 2 mg/cm2 thick. All plastic films
less than 2 mg/cm2 which were tried exhibited leakage. It was found, however, that mica
could be split to the desired thickness, and if handled carefully to avoid cracking, would
not leak.
The mica window was cut from a thick sheet of mica, which was then split to the desired
thinness. Mica was split by first teasing the edge of the mica disk to separate the layers.
The point of a fine needle was inserted a short distance to separate the layers, following
which water was allowed to flow into the spaces between. The water, which was supplied
by touching the needle with a wet brush tip, flows ahead of the needle, separating the
TABLE I
Thorium X Disintegration Series
ENERGY OP RADIATION IN MEV
NAME SYMBOL EALP-LD'E
Alpha Beta Gamma
—Thorium X ssRa224 3.64 days 5.68 —
Thoron ,6Rn"° 54.5 sec. 6.28 — —
Thorium A ,4Po216 .158 sec. 6.77 — —
Thorium B ,2Pb21' 10.6 hrs. — 0.36 —













Thorium D ,2Pb20' Stable — — —
layers by capillarity, and preventing the needle from scratching the mica. With skill, a
good grade of mica can be split to thicknesses of 1 to 2 mg/cm'. It is possible to secure
pieces as thin as % mg/cm2, though the pieces are fragile and the process very time con-
suming.
The second problem involved the choice of a proper cement for fixing the thin film to
its support. The thin plastic films were destroyed quickly by cements containing a solvent
and it was therefore necessary to use a polymerizing agent.* The thin mica windows were
best cemented by a common commercial adhesive**, which shrinks on drying. This shrink-
age was advantageous in that it pulled down the edges of the mica and helped prevent
splitting.
The window material—plastic or mica—was mounted on a plastic ring, as shown in
Figure 1. The ring is circular, inch in outside diameter, and 1 cm. in inside diameter.
In order to cement the window material in place one of the flat surfaces of the ring was
given a thin coat of the chosen adhesive. The circular piece of plastic or mica was then
placed on the wet adhesive, and another thin coat of the same adhesive cement was ap-
plied to the surface of the film over its outer edge.
A plastic plug, machined from the same plastic as the ring, was made with a diameter
a fraction less than 1 cm., thus making for a tight fit when inserted into the ring. An al-
coholic solution of thorium X, was pipetted onto the end of the plastic plug and dried
* Bonding Agent R-313, Carl Biggs Co., Los Angeles 64, California.
** Duco Cement, DuPont.
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under a heat lamp. This plug was inserted into the plastic ring carrying the thin film and
the assembly was sealed by running cement (Duco) around the edge of the plug. After 30
minutes for setting of the cement, the plaque was ready for application to the skin.
The plaque just described (Figure 1) is the result of several modifications of the design
first used.
Measurement of Output from Plaques
The plaques were measured in terms of the dose unit, the rep (roentgen-equivalent-
physical). This unit, defined as the amount of ionizing radiation which gives 93 ergs to
each gram of tissue, is the unit in which alpha and beta particles are measured, and cor-
responds to the roentgen for x-rays. One r of x-rays gives 93 ergs/gram of tissue. The cali-
bration of the plaques consists in measuring the ionization in a small air volume at the
surface of the plaque by means of a special ionization chamber called an "extrapolation
chamber". This instrument measures the ionization in terms of esu/cc, and then calcula-
tion gives the dose rate in terms of rep. A detailed description of the instrument, its use,
and the calculations involved are being published elsewhere (6).
CLINICAL APPLICATION
The sealed plaques loaded with thorium X were applied to the anterior aspect
of the forearm or to the antero-medial aspect of the upper arm of subjects selected
among patients being treated at the Skin and Cancer Unit of the University Hos-
pital. The plaques were firmly taped to an apparently normal skin area and al-
lowed to remain in place for 48 hours. The subjects were instructed to keep this
area dry.
The plaques were removed after 48 hours of continuous exposure and the areas
were observed for visible biologic effects. Where pressure of the plaque or irritat-
ing effects of the adhesive tape were thought to be factors in the production of
redness, the test sites were reread one to five days later. Any remaining clinically
discernible redness was considered to be an erythema produced by the thorium
X emanations.
Immediately after removal of the plaques the areas of skin which had been
exposed were surveyed with a thin-windowed Geiger-Muller tube connected to an
electronic scaling unit. The presence of any alpha or beta particles was readily
recorded by this equipment. If leakage of the radioactive thorium X had occurred
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FIG. 1. Schematic drawing of thorium X plaque.
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any time during the test period it was thus detected. Sites with activity appre-
ciably above the normal background, as determined by counting the normal
unexposed, contralateral side of the body, were considered to be contaminated
by a leaking plaque and the biologic reactions of these sites were therefore not
considered as suitable for inclusion in this study.*
Early in the study only one plaque was applied to any one subject, but later
both an "alpha" and "beta-gamma" plaque were tested on different sites at the
same time.
RESULTS
During the course of the study a total of 140 plaques were applied to 96 sub-
jects. Of these, 75 were "alpha" plaques and 65 were "beta-gamma" plaques. Sixty
of the plaques leaked and the skin observations in these instances were necessarily
discarded.
When the exposed sites were observed at the time the plaques were removed
there was either no reaction or a minimal erythematous response. In no instance
did the degree of erythema approximate the intense erythematous response that
follows the direct application of an equal amount of alcoholic solution of thorium
X to the skin.
Our observations were difficult to interpret until we were able to control the
study by applying a "matched" pair of plaques on each subject. This consisted
of loading an "alpha" and "beta-gamma" plaque with approximately equal
amounts of thorium X and applying them simultaneously to adjacent areas of the
skin. This procedure gave two skin areas which received similar beta-gamma
doses** (from both the "alpha" plaque and the "beta-gamma" plaque); while
only one of these areas received an alpha dose (solely from the "alpha" plaque).
Fourteen such pairs of plaques were applied and left in place for 48 hours. The
"alpha" plaques produced erythema in 11 of the 14 cases. The "beta-gamma"
plaques applied at the same time as the "alpha" plaques produced a questionable
or barely discernible small macule of erythema in 9 cases and no reaction in 5.
Pressure effects and irritation produced by the adhesive taping made it extremely
difficult to interpret these poorly-developed erythemas.
The reactions were decidedly easier to read and interpret when the sites were
reexamined one to five days later, after the effects of irritation had disappeared.
Eleven of the subjects returned for follow-up examination. In seven of these the
areas exposed to the "alpha" plaques presented a fairly well-defined erythema,
some with pigmentation. This reaction conformed to the window area of the
plaques. The remaining four subjects showed reaction involving more than one-
half of the irradiated site. Three of the areas had an irregularly-shaped approxi-
* The specific criterion used was the following: plaques were considered as possibly
having leaked if the increase in counting rate was 25 or more counts per minute above
background. In our experience this increase above background could not be held respon-
sible for the production of erythema.
** The beta-gamma output from each plaque was measured as previously described.
The alpha output from the "alpha" plaque was also recorded.
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mately 2—3 mm. macule of slightly greater reaction. These macules corresponded
to a point of accumulation of thorium X, or "hot-spot", within the plaque. On
reexamination the areas exposed to the "beta-gamma" plaques presented findings
quite different than those for the alpha plaques; in only one instance did the
"beta-gamma" plaques produce reaction which conformed to the size of the
plaque window. In two other cases one could note a questionable erythematous
response with pigmentation over approximately two-thirds of the irradiated sites.
The barely discernible erythematous macules noted when the plaques were re-
moved were slightly more apparent in the absence of the irritation effects in 5
t,ases. These small erythematous and pigmented macules were produced by "hot-
spots" in the "beta-gamma" plaques and correspond to those seen with the
"alpha" plaques.
DISCUSSION
When the evaluation of the relative biologic effectiveness of the alpha and beta-
gamma components of thorium X was undertaken it was obvious that there
would be differences between the experimental methods and the actual clinical
use of the radioactive material.
It was anticipated that thorium X enclosed in a plaque, whether in an "alpha"
or a "beta-gamma" transmitting plaque, would have a biologic effect on human
skin in vivo quite different in degree from the effect produced by an equal quantity
in alcoholic solution pipetted directly on the epidermal surface. This was evident
from the very mild erythema produced by a plaque left in place for 48 hours, as
contrasted to the very marked erythematous response produced by the same
amount of thorium X solution pipetted directly on an equal area of skin surface.
This difference is believed to be due to the actual penetration of the radioactive
element, thorium X, into the epidermis and its appendages thus enhancing the
biologic effect many times.
The study was further limited by the fact that it was impossible to separate
thorium X alpha from the beta and gamma emanations and to pipette a solution
of either one or the other onto the skin's surface. The most that could be done
was to filter the alpha particles from the total alpha-beta-gamma spectrum and
leave only the beta-gamma radiation. In order to achieve this the thorium X
"alpha" and "beta-gamma" plaques were designed.
The results show that the "alpha" plaques produce an erythema conforming
in area to the entire or to a major part of the active surface of the window, while
the "beta-gamma" plaques applied at the same time to an adjacent site produce
such a reaction in only rare instances and then in much less degree. It is con-
cluded, therefore, that the visible biologic effects are due to the alpha particles
emanating from the "alpha" plaques. This observation is of paramount interest
in that it demonstrates for the first time that alpha particles bombarding human
skin from the surface are capable of producing clinically visible biologic effects.
This finding is contradictory to the many statements that appear in the literature
which disclaim any biologic effect for alpha particles acting on the skin from the
surface.
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The small, irregular erythematous macules produced by both types of plaques
are explained by the uneven distribution of thorium X within the plaque and
accumulation at one site to form a "hot-spot". The beta-gamma output from
these spots is sufficiently high to produce visible biologic effects.
Our studies indicate that the beta and gamma components of thorium X are
capable of producing an erythematous response on human skin. The extent of our
observations together with various difficulties encountered make it impossible to
state the threshold erythema dose for this radiation. Based on the present study,
however, it may be said that 1) the relative biologic effectiveness of the beta and
gamma component of thorium X is many times less than that of the alpha com-
ponent as judged from the degree of erythema and pigmentation produced, 2) it
is evident that whatever the biologic effectiveness of the beta and gamma radia-
tion the total dose present in the amount of thorium X customarily used on hu-
man skin is relatively small. This confirms forty years of clinical experience with
thorium X, which have shown it to be incapable of producing serious sequelae
and have demonstrated its wide margin of safety as used in the treatment of vari-
ous dermatoses.
We believe that these inferences are justified in spite of the many uncontrol-
lable factors in our studies. Among these factors are those producing variations
in plaque output (differences in window thickness, unequal loading with thorium
X, uneven distribution of thorium X inside the plaque), human variations in
biologic response, and the difficulties of interpreting the subtler shades of ery-
thema.
SUMMARY
The relative biologic effectiveness of the alpha and beta-gamma rays from
thorium X was studied by utilizing specially prepared thin-window plaques ap-
plied to the skin of human subjects. These plaques were constructed to seal in the
thorium X and thus prevent the vehicle and the thorium X atoms from penetrat-
ing into the epidermis and its appendages but at the same time permit the
radiation to reach the skin. Two types of thin window plaques were used: 1) with
a window material thin enough to transmit the alpha, beta and gamma radiation
and 2) with a window material of sufficient thickness to absorb the alpha particles
but thin enough to transmit the beta and gamma radiation.
Conclusions are drawn from the results obtained with 80 plaques applied to
58 subjects.
1. The degree of erythema produced by the plaques containing thorium X is
small in contrast to the intense ery-thematous response that results from the direct
application of an equal amount of alcoholic solution of thorium X to an equal
area of skin.
This difference is believed to be due to the fact that when the thorium X solu-
tion is pipetted directly onto the skin the actual penetration of the radioactive
element, thorium X, into the epidermis and its appendages, produces a major
portion of the biologic effect.
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2. Nevertheless, alpha particles bombarding the skin from the surface are capa-
ble of producing erythema and pigmentation.
3. The relative biologic effectiveness of the beta and gamma components of
thorium X is many times less than that of the alpha component as judged by the
degrees of erythema and pigmentation produced.
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DISCUSSION
DR. HERMANN PINKUS, Monroe, Michigan: We should congratulate Dr. Wit-
ten and his associates on the ingenious continuation of the fine work which he
reported last year. I think these basic studies on thorium X were badly needed.
It is good that somebody did them and did them in such a thorough and well
planned way. The fact that the alpha rays of thorium X, when the thorium X
itself cannot get on the skin but only the alpha particles, have a much smaller
effect than otherwise, bears out what Dr. Witten has shown before, that thorium
X actually penetrates into the epidermis if it is applied to the skin surface in the
usual manner.
One point that I would like to inquire about is contained in a very short report
in Nature of last October (Rottier, P. B. and Mullink, J. A. M.: Localization of
erythemal processes caused by ultra-violet light in human tissues. Nature 170:
574, 1952). These authors found that ultraviolet rays of 300m produced ery-
thema whether they act on the normal skin or on skin from which the horny layer
had been stripped off with Scotch tape. But if they used the short ultraviolet
rays of 250 mgi, then there was no effect on the stripped skin which had lost its
horny layer. The authors concluded that most likely these short rays produce
their primary effect on some substance in the keratin layer and that the erythema
is produced secondarily by the chemically altered substance which diffuses down
from the keratin layer. I wonder if this mechanism might have some application
in the action of thorium X.
DR. VICTOR H. Wnh'EN (in closing): I wish to thank Dr. Pinkus for his discus-
sion. It is possible that radiation, other than ultraviolet, which is incapable of
penetrating any further than the epidermis can produce secondary changes. That
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possibility also holds for thorium X, in which the greater part of the alpha radia-
tion bombards the epidermis. Doctor Sulzberger and I in a recent article (Der
Hautarzt, 11: 521, 1952) speculated concerning the modes of action of thorium X
applied to human skin. Among various other considerations we mention the possi-
bility of secondary effects playing a role.
The range of the most energetic alpha particles in tissue is, at the most, 95
microns. The average thickness of the epidermis varies from 30 to 70 microns.
Of course, it is much thicker in some places and thinner in other. If the alpha
particles liberated from thorium X applied to the surface of the skin travel 95
microns they could well go into the papillary body and directly bombard the
papillary tissue. In original work done many years ago and published in the
llandbuch der Haut- und Geschlechtskrankheiten it was shown that the primary
histopathologic changes produced by thorium X were in the papillary bodies.
These facts permit the speculation that the alpha particles reach the papillary
body and there produce biologic effects.
